Cardiac glycosides used in pediatric patients
Digoxin is the cardiac glycoside used in pediatric patients for conditions requiring a positive inotrope and/or rate-control effect, with established pediatric pharmacokinetic data supporting its use. [1]
Digitoxin has been used in pediatric patients in clinical practice reports, including long-term therapy in a child with endocardial fibroelastosis. [2]
Ouabain is a cardiac glycoside whose clinical use in pediatric patients is not established as a standard therapy in contemporary pediatric practice documents and is not the primary glycoside used. [3]